Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Concise Review: Prostate Cancer Stem Cells: Current Understanding
Sergej Skvortsov, Ira Skvortsova, Dean G. Tang, et al.
Stem Cells (2018) Vol. 36, Iss. 10, pp. 1457-1474
Open Access | Times Cited: 119

Showing 1-25 of 119 citing articles:

Emerging role of tumor cell plasticity in modifying therapeutic response
Siyuan Qin, Jingwen Jiang, Yi Lü, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 198
Dichloroacetate (DCA) and Cancer: An Overview towards Clinical Applications
Tiziana Tataranni, Cláudia Piccoli
Oxidative Medicine and Cellular Longevity (2019) Vol. 2019, pp. 1-14
Open Access | Times Cited: 194
BRCA Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance
Ielizaveta Gorodetska, Iryna Kozeretska, Anna Dubrovska
Journal of Cancer (2019) Vol. 10, Iss. 9, pp. 2109-2127
Open Access | Times Cited: 188
MicroRNA-34a: Potent Tumor Suppressor, Cancer Stem Cell Inhibitor, and Potential Anticancer Therapeutic
Wen Li, Yunfei Wang, Ruifang Liu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 125
GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy
Anna Mukha, Uğur Kahya, Annett Linge, et al.
Theranostics (2021) Vol. 11, Iss. 16, pp. 7844-7868
Open Access | Times Cited: 113
ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and RAR-dependent transcription
Ielizaveta Gorodetska, Anne Offermann, Jakob Püschel, et al.
Theranostics (2024) Vol. 14, Iss. 2, pp. 714-737
Open Access | Times Cited: 21
In silico oncology: a mechanistic multiscale model of clinical prostate cancer response to external radiation therapy as the core of a digital (virtual) twin. Sensitivity analysis and a clinical adaptation approach
Georgios Stamatakos, Eleni Kolokotroni, Foteini Panagiotidou, et al.
Frontiers in Physiology (2025) Vol. 16
Open Access | Times Cited: 2
Dormant, quiescent, tolerant and persister cells: Four synonyms for the same target in cancer
François M. Vallette, Olivier D. Christophe, Frédéric Lézot, et al.
Biochemical Pharmacology (2018) Vol. 162, pp. 169-176
Open Access | Times Cited: 161
Cancer Stem Cell Plasticity – A Deadly Deal
Archana P. Thankamony, Kritika Saxena, Reshma Murali, et al.
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 139
The long non-coding RNA LncHDAC2 drives the self-renewal of liver cancer stem cells via activation of Hedgehog signaling
Jiayi Wu, Pingping Zhu, Tiankun Lu, et al.
Journal of Hepatology (2018) Vol. 70, Iss. 5, pp. 918-929
Closed Access | Times Cited: 111
The key roles of cancer stem cell-derived extracellular vesicles
Chaoyue Su, Jianye Zhang, Yosef Yarden, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 97
The Contributions of Prostate Cancer Stem Cells in Prostate Cancer Initiation and Metastasis
Wenjuan Mei, Xiaozeng Lin, Anil Kapoor, et al.
Cancers (2019) Vol. 11, Iss. 4, pp. 434-434
Open Access | Times Cited: 95
Slow-cycling (dormant) cancer cells in therapy resistance, cancer relapse and metastasis
Sukanya Basu, Dong Yang, Rahul Kumar, et al.
Seminars in Cancer Biology (2021) Vol. 78, pp. 90-103
Open Access | Times Cited: 88
Natural Compounds in Prostate Cancer Prevention and Treatment: Mechanisms of Action and Molecular Targets
Fabrizio Fontana, M. Raimondi, Monica Marzagalli, et al.
Cells (2020) Vol. 9, Iss. 2, pp. 460-460
Open Access | Times Cited: 87
Understanding and targeting prostate cancer cell heterogeneity and plasticity
Dean G. Tang
Seminars in Cancer Biology (2021) Vol. 82, pp. 68-93
Open Access | Times Cited: 63
Biomaterial-based platforms for modulating immune components against cancer and cancer stem cells
Nimeet Desai, Uzma Hasan, K. Jeyashree, et al.
Acta Biomaterialia (2023) Vol. 161, pp. 1-36
Open Access | Times Cited: 25
Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies
Giulia Ambrosini, Marco Cordani, Ali Zarrabi, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Prostate Stem Cells and Cancer Stem Cells
Jia J. Li, Michael M. Shen
Cold Spring Harbor Perspectives in Medicine (2018) Vol. 9, Iss. 6, pp. a030395-a030395
Open Access | Times Cited: 72
BRCA1 and EZH2 cooperate in regulation of prostate cancer stem cell phenotype
Ielizaveta Gorodetska, Vasyl Lukiyanchuk, Claudia Peitzsch, et al.
International Journal of Cancer (2019) Vol. 145, Iss. 11, pp. 2974-2985
Open Access | Times Cited: 64
The Role of Dielectrophoresis for Cancer Diagnosis and Prognosis
Giorgio Ivan Russo, Nicolò Musso, Alessandra Romano, et al.
Cancers (2021) Vol. 14, Iss. 1, pp. 198-198
Open Access | Times Cited: 53
Targeting CSC-related transcription factors by E3 ubiquitin ligases for cancer therapy
Weijia Wang, Wenjun Liu, Qiuli Chen, et al.
Seminars in Cancer Biology (2022) Vol. 87, pp. 84-97
Closed Access | Times Cited: 30
CD98 heavy chain as a prognostic biomarker and target for cancer treatment
Xia Pu, Anna Dubrovska
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 18
Targeted immunotherapy to cancer stem cells: A novel strategy of anticancer immunotherapy
Shanyong Yi, Mei-Zhuo Wei, Ling Zhao
Critical Reviews in Oncology/Hematology (2024) Vol. 196, pp. 104313-104313
Closed Access | Times Cited: 8
New advances of the androgen receptor in prostate cancer: report from the 1st International Androgen Receptor Symposium
Sherif Mehralivand, Christian Thomas, Martin Puhr, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Cancer-associated fibroblasts and prostate cancer stem cells: crosstalk mechanisms and implications for disease progression
Haoran Chen, Su-Ping Fang, Xudong Zhu, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top